Jianjun Zhang

Find an error

Name:
Organization: Institute of Materia Medica
Department: State Key Laboratory of Bioactive Substance and Function of Natural Medicines
Title:
Co-reporter:Lirui Qiao, Chengxue Ji, Dewu Zhang, Lin Yang, Ridao Chen, Jianjun Zhang, Jungui Dai
Tetrahedron 2014 70(22) pp: 3560-3569
Publication Date(Web):
DOI:10.1016/j.tet.2014.04.011
Co-reporter:Dan Zhang;Geng-tao Liu;Jian-gong Shi;Jian-jun Zhang
Basic & Clinical Pharmacology & Toxicology 2006 Volume 98(Issue 1) pp:
Publication Date(Web):24 JAN 2006
DOI:10.1111/j.1742-7843.2006.pto_218.x

Abstract: Previous studies have shown that injection of D-galactose could result in senescent performances in animals, that injection of NaNO2 could cause ischaemia and hypoxia in many organs, and combined injection of D-galactose and NaNO2 make normal mice taking on senescent performances in a shorter period. The aim of this study was to investigate the effects of CE, an extract from a Tibetan medicinal herb, Coeloglossum. viride(L.)Hartm. var. bracteatum(Willd.), on senescent mice. The step-down test was performed to evaluate the learning and memory function of mice. The activities of superoxide dismutase, adenosine triphosphatase, monoamine oxydase and the content of malondialdehyde were measured to determine the impairment of brain. The expressions of Bcl-2, Bax, and caspase-3 proteins in mouse hippocampus were studied by immunohistochemical staining. The data demonstrated that D-galactose and NaNO2 treated mice had significant deficits in learning and memory function. The reduced activities of superoxide dismutase, adenosine triphosphatase, increased activities of monoamine oxydase and level of malondialdehyde were also found. Bax and caspase-3 positive cells increased while Bcl-2 positive cells decreased remarkably. Treatment of CE (2.5, 5 mg · kg−1) ameliorated the memory impairment; rectified the biochemistry and neural system changes in mice. These results suggest that CE offers promise as a tool for treatment of senescence-related diseases.

Co-reporter:Lili Liu, Shaobo Jia, Jingwen Dong, Ying Zhang, Ruiming Xu, Jianjun Zhang
Acta Pharmaceutica Sinica B (July 2013) Volume 3(Issue 4) pp:
Publication Date(Web):1 July 2013
DOI:10.1016/j.apsb.2013.05.005
This study was to examine the sedative–hypnotic effect of YZG-330 and its influence on Cl− influx in mouse cortical cells. In a sleep time-prolongation test in which mice were administered a threshold dosage of sodium pentobarbital (ip), YZG-330 (0.125, 0.5 and 2 mg/kg, po) prolonged the sleep time by 25% (P>0.05), 64% (P<0.01) and 506% (P<0.001), respectively. Thereafter, treatment with YZG-330 permitted mice that had woken up after the threshold dose of sodium pentobarbital (ip) to fall asleep again. A Cl−-sensitive fluorescent probe, N-(ethoxycarbonylmethyl)-methoxyquinolinium bromide (MQAE), was used to determine the effect of YZG-330 on Cl− influx. YZG-330 (0.3, 0.6 and 1.5 mM) increased Cl− influx in mouse cortical cells in a concentration-dependent manner. These data suggest that YZG-330 has a hypnotic effect in mice, and the effect may be related to an increase in Cl− influx in cortical cells.YZG-330 (0.3, 0.6 and 1.5 mM) increased Cl− influx in mouse cortical cells in a concentration-dependent manner. These data suggest that YZG-330 has a hypnotic effect in mice, and the effect may be related to an increase in Cl− influx in cortical cells.Download full-size image
Co-reporter:Min Li, Ruixia Kang, Shaobo Jia, Jiangong Shi, GengTao Liu, JianJun Zhang
Pharmacology Biochemistry and Behavior (February 2014) Volume 117() pp:151-156
Publication Date(Web):1 February 2014
DOI:10.1016/j.pbb.2013.12.016
•B2 is a novel adenosine analog.•B2 produces sedative and hypnotic effects in mice by oral administration.•Adenosine A1 and A2A receptors may be involved in the central effect of B2.•B2 activates VLPO neurons in the sleep center of anterior hypothalamus.N6-(3-methoxyl-4-hydroxybenzyl) adenine riboside (B2) is an N6-substitued adenosine analog. Previous studies have shown that B2 binds to the adenosine A1 and A2A receptors with moderate affinity and produces protective effects on serum deprivation-induced cell damage. However, central nervous system effects of B2 have not been studied. We aimed to investigate the sedative and hypnotic effects and the mechanism of action of B2 in mice. Our behavioral studies showed that oral administration of B2 decreased spontaneous locomotor activity and potentiated the hypnotic effect of pentobarbital in mice. Sleep architecture analyses revealed that B2 decreased wakefulness and increased non-rapid eye movement (NREM) sleep in both normal mice and mice with caffeine-induced insomnia. Using immunohistochemistry, we showed that B2 increased c-Fos expression, a cellular marker for neuronal activity, in the ventrolateral preoptic (VLPO) area, a sleep center in the anterior hypothalamus. Altogether, these results indicate that oral administration of B2 produces sedative and hypnotic effects. Furthermore, the activation of VLPO neurons may be involved in the central depressant effects of B2.
N6-(4-Hydroxybenzyl)-adenosine
pentobarbital methanol solution
Ethanaminium,2-hydroxy-N,N,N-trimethyl-